Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 299

Similar articles for PubMed (Select 22629396)

1.

Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.

Niki Y, Takeuchi T, Nakayama M, Nagasawa H, Kurasawa T, Yamada H, Toyama Y, Miyamoto T.

PLoS One. 2012;7(5):e37447. doi: 10.1371/journal.pone.0037447. Epub 2012 May 21.

2.

[Clinical significance of serum cartilage biomarkers in the treatment of rheumatoid arthritis with biological therapy].

Niki Y, Takeuchi T.

Clin Calcium. 2012 Feb;22(2):205-12. doi: CliCa1202205212. Review. Japanese.

PMID:
22298074
3.

Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.

Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.

Arthritis Rheum. 2005 Mar;52(3):885-91.

PMID:
15751093
4.

Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.

Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.

Arthritis Rheum. 2003 Nov;48(11):3085-95.

PMID:
14613270
5.

Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.

Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC Jr.

J Rheumatol. 2005 Oct;32(10):1911-7.

PMID:
16206346
6.

Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.

Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, Bijlsma JW, Lafeber FP; Utrecht Rheumatoid Arthritis Cohort Study group (SRU).

Arthritis Res Ther. 2006;8(1):R31. Epub 2006 Jan 10.

7.

Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.

Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB.

Arthritis Rheum. 2006 Aug;54(8):2496-504.

PMID:
16868970
9.

Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis.

Hosogane N, Watanabe K, Tsuji T, Miyamoto T, Ishii K, Niki Y, Nakamura M, Toyama Y, Chiba K, Matsumoto M.

J Orthop Res. 2012 Aug;30(8):1249-53. doi: 10.1002/jor.22067. Epub 2012 Jan 13.

PMID:
22247038
11.

Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.

Conrozier T, Poole AR, Ferrand F, Mathieu P, Vincent F, Piperno M, Verret C, Ionescu M, Vignon E.

Clin Exp Rheumatol. 2008 May-Jun;26(3):430-5.

PMID:
18578964
12.
13.

Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.

Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S.

J Rheumatol. 2012 Jul;39(7):1341-7. doi: 10.3899/jrheum.111401. Epub 2012 Jun 1.

PMID:
22660798
14.

The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial.

Bakker MF, Verstappen SM, Welsing PM, Jacobs JW, Jahangier ZN, van der Veen MJ, Bijlsma JW, Lafeber FP; Utrecht Arthritis Cohort study group.

Arthritis Res Ther. 2011 May 8;13(3):R70. doi: 10.1186/ar3331.

15.

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.

Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.

Ann Rheum Dis. 2008 Mar;67(3):353-7. Epub 2007 Jul 20.

PMID:
17644538
16.

Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, FitzGerald O, Poole AR, Bresnihan B, Veale DJ, Fearon U.

Arthritis Rheum. 2012 Apr;64(4):1035-45. doi: 10.1002/art.33455. Epub 2011 Nov 10.

PMID:
22076945
17.

Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes.

Sunk IG, Demetriou D, Szendroedi J, Amoyo L, Raffetseder A, Hörl WH, Sunder-Plassmann G, Smolen JS, Bobacz K.

Osteoarthritis Cartilage. 2008 Nov;16(11):1336-42. doi: 10.1016/j.joca.2008.03.024. Epub 2008 May 5.

18.

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.

Pedersen SJ, Sørensen IJ, Lambert RG, Hermann KG, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M.

Arthritis Rheum. 2011 Dec;63(12):3789-800. doi: 10.1002/art.30627.

PMID:
22127697
19.

The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.

Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.

Arthritis Rheum. 2009 Jan;60(1):290-8. doi: 10.1002/art.24184.

PMID:
19116938
20.

Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy.

Mullan RH, Matthews C, Bresnihan B, FitzGerald O, King L, Poole AR, Fearon U, Veale DJ.

Arthritis Rheum. 2007 Sep;56(9):2919-28.

PMID:
17763421
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk